Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States.
Singh B N·The American journal of cardiology
Bepridil is a unique calcium antagonist with a broad pharmacologic profile and demonstrated efficacy as an antianginal agent. Data from US clinical trials of bepridil in 840 patients (820 with chronic stable angina; 20 with vasospastic angina) indicated that the drug is well tolerated. The most frequent adverse reactio…